22 November 2024
22 November 2024
The pilot by the FDA’s CDRH will improve communications about corrective actions being taken over certain medical device recalls.
The company's move towards an IPO aligns with a wave of high-profile potential listings for the next year.
Events like the RFK Jr nomination as US HHS head, Labour’s 10-year plan, and centralised EU funding will steer the sector’s future.
The University Health Network (UHN) hospital has been selected as the site for this study.
Trump's nomination of Dr Oz has raised eyebrows, as a history of big pharma financial ties and questionable science hangs over him.
The company’s VP of digital excellence explains how the Japanese biotech engages with data and uses it to inform decision making.
Novocure has refined the transducer arrays that attach to Optune Gio, its wearable for glioblastoma treatment.
The solution offers clinicians detailed patient reports, which feature important cardio acoustic biomarkers.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
